#National Comprehensive Cancer Network

Study finds bone health testing for patients with prostate cancer undergoing ADT therapy are not meeting guideline recommendations.

The NCCN publishes free treatment recommendations for pediatric Hodgkin lymphoma, adding to growing library of pediatric cancer guidelines.

New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations.

New research discusses how immunotherapy-related adverse events (irAEs) can impact more than one organ in a single patient.

The NCCN Distress Thermometer enables discussion and treatment of distress as part of routine care for people with cancer.

New research from UCSF and City of Hope examines limitations in coverage for liquid biopsy genomic testing in cancer care.

Information for patients and caregivers on how to manage adverse events from immune checkpoint inhibitors

New NCCN guidelines explain how to recognize and manage immunotherapy-related toxicities.

Researchers discover 40.2% of advanced cancer patients with unplanned hospitalizations experienced functional impairment.

National Comprehensive Cancer Network guidelines offer expert advice on treatment and prevention.

These guidelines can help minimize exposure risk while also preserving resources for those with the most immediate need for care.

COVID-19 has disrupted care and raised treatment safety concerns. These trustworthy sources can help you stay up to date.

Experts from Seattle Cancer Care Alliance share lessons from early experiences treating people with cancer during the COVID-19 outbreak.

“Young adult survivors are more vulnerable to financial instability for many reasons related to the tasks of young adult development."

A new study points to need for greater efforts to reduce racial disparities in cancer survival and increase access to health care.

NCCN Patient Advocacy Summit examines the patient perspective on delivering value and high-quality care.